Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fairhaven Pro for Men in male infertility
NCT03464656Phase 4Unknown
- Sponsor
- Hamad Medical Corporation
- Start
- Jan 2018
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in male infertility, sponsored by Hamad Medical Corporation. Primary endpoints: Sperm motility at 1 year, Sperm morphology at 1 year and 1 more. Status: unknown.
02
Conditions
male infertility
Beyond the preview
Go deeper on NCT03464656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03464656.